Imaging-Guided Acute Ischemic Stroke Therapy: From “Time Is Brain” to “Physiology Is Brain”

References

1. ↵
   NINDS Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581–87

   CrossRefPubMedWeb of Science
2. ↵
   Gonzalez RG, Hirsch J, Koroshetz W, et al. Acute Ischemic Stroke: Imaging and Intervention. Berlin, Germany: Springer-Verlag; 2006
3. ↵
   Lisboa RC, Jovanovic BD, Alberts MJ. Analysis of the safety and efficacy of intra-arterial thrombolytic therapy in ischemic stroke. Stroke 2002;33:2866–71

   Abstract/FREE Full Text
4. ↵
   Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke: The PROACT II study—a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 1999;282:2003–11

   CrossRefPubMedWeb of Science
5. ↵
   Smith WS, Sung G, Starkman S, et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 2005;36:1432–38

   Abstract/FREE Full Text
6. ↵
   Cocho D, Belvis R, Marti-Fabregas J, et al. Reasons for exclusion from thrombolytic therapy following acute ischemic stroke. Neurology 2005;64:719–20

   Abstract/FREE Full Text
7. ↵
   Katzan IL, Furlan AJ, Lloyd LE, et al. Use of tissue-type plasminogen activator for acute ischemic stroke: the Cleveland area experience. JAMA 2000;283:1151–58

   CrossRefPubMedWeb of Science
8. ↵
   Smith MA, Doliszny KM, Shahar E, et al. Delayed hospital arrival for acute stroke: the Minnesota Stroke Survey. Ann Intern Med 1998;129:190–96

   CrossRefPubMedWeb of Science
9. ↵
   Adams HP Jr, Brott TG, Furlan AJ, et al. Guidelines for thrombolytic therapy for acute stroke: a supplement to the guidelines for the management of patients with acute ischemic stroke—a statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association. Circulation 1996;94:1167–74

   FREE Full Text
10. ↵
    Adams HP Jr, Adams RJ, Brott T, et al. Guidelines for the early management of patients with ischemic stroke: a scientific statement from the Stroke Council of the American Stroke Association. Stroke 2003;34:1056–83

    FREE Full Text
11. ↵
    Hacke W, Donnan G, Fieschi C, et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004;363:768–74

    CrossRefPubMedWeb of Science
12. ↵
    Wardlaw JM. Overview of Cochrane thrombolysis meta-analysis. Neurology 2001;57(suppl 2):S69–76
13. ↵
    Albers GW, Bates VE, Clark WM, et al. Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study. JAMA 2000;283:1145–50

    CrossRefPubMedWeb of Science
14. ↵
    Grond M, Stenzel C, Schmulling S, et al. Early intravenous thrombolysis for acute ischemic stroke in a community-based approach. Stroke 1998;29:1544–49

    Abstract/FREE Full Text
15. Chiu D, Krieger D, Villar-Cordova C, et al. Intravenous tissue plasminogen activator for acute ischemic stroke: feasibility, safety, and efficacy in the first year of clinical practice. Stroke 1998;29:18–22

    Abstract/FREE Full Text
16. Trouillas P, Nighoghossian N, Derex L, et al. Thrombolysis with intravenous rtPA in a series of 100 cases of acute carotid territory stroke: determination of etiological, topographic, and radiological outcome factors. Stroke 1998;29:2529–40

    Abstract/FREE Full Text
17. Tanne D, Bates VE, Verro P, et al. Initial clinical experience with IV tissue plasminogen activator for acute ischemic stroke: a multicenter survey: the t-PA Stroke Survey Group. Neurology 1999;53:424–27

    Abstract/FREE Full Text
18. Akins PT, Delemos C, Wentworth D, et al. Can emergency department physicians safely and effectively initiate thrombolysis for acute ischemic stroke? Neurology 2000;55:1801–05

    Abstract/FREE Full Text
19. Wang DZ, Rose JA, Honings DS, et al. Treating acute stroke patients with intravenous tPA: the OSF stroke network experience. Stroke 2000;31:77–81

    Abstract/FREE Full Text
20. Lopez-Yunez AM, Bruno A, Williams LS, et al. Protocol violations in community-based rTPA stroke treatment are associated with symptomatic intracerebral hemorrhage. Stroke 2001;32:12–16

    Abstract/FREE Full Text
21. Bravata DM, Kim N, Concato J, et al. Thrombolysis for acute stroke in routine clinical practice. Arch Intern Med 2002;162:1994–2001

    CrossRefPubMedWeb of Science
22. Merino JG, Silver B, Wong E, et al. Extending tissue plasminogen activator use to community and rural stroke patients. Stroke 2002;33:141–46

    Abstract/FREE Full Text
23. ↵
    Tanne D, Kasner SE, Demchuk AM, et al. Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: the Multicenter rt-PA Stroke Survey. Circulation 2002;105:1679–85

    Abstract/FREE Full Text
24. ↵
    Albers GW, Amarenco P, Easton JD, et al. Antithrombotic and thrombolytic therapy for ischemic stroke: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126(suppl):483S–512S

    CrossRefPubMedWeb of Science
25. ↵
    Barnwell SL, Clark WM, Nguyen TT, et al. Safety and efficacy of delayed intraarterial urokinase therapy with mechanical clot disruption for thromboembolic stroke. AJNR Am J Neuroradiol 1994;15:1817–22

    Abstract/FREE Full Text
26. ↵
    Qureshi AI. New grading system for angiographic evaluation of arterial occlusions and recanalization response to intra-arterial thrombolysis in acute ischemic stroke. Neurosurgery 2002;50:1405–15

    CrossRefPubMedWeb of Science
27. Kerber CW, Barr JD, Berger RM, et al. Snare retrieval of intracranial thrombus in patients with acute stroke. J Vasc Interv Radiol 2002;13:1269–74

    PubMedWeb of Science
28. Qureshi AI, Siddiqui AM, Kim SH, et al. Reocclusion of recanalized arteries during intra-arterial thrombolysis for acute ischemic stroke. AJNR Am J Neuroradiol 2004;25:322–28

    Abstract/FREE Full Text
29. Ueda T, Sakaki S, Nochide I, et al. Angioplasty after intra-arterial thrombolysis for acute occlusion of intracranial arteries. Stroke 1998;29:2568–74

    Abstract/FREE Full Text
30. Nakayama T, Tanaka K, Kaneko M, et al. Thrombolysis and angioplasty for acute occlusion of intracranial vertebrobasilar arteries: report of three cases. J Neurosurg 1998;88:919–22

    PubMedWeb of Science
31. Ringer AJ, Qureshi AI, Fessler RD, et al. Angioplasty of intracranial occlusion resistant to thrombolysis in acute ischemic stroke. Neurosurgery 2001;48:1282–90

    CrossRefPubMedWeb of Science
32. Ramee SR, Subramanian R, Felberg RA, et al. Catheter-based treatment for patients with acute ischemic stroke ineligible for intravenous thrombolysis. Stroke 2004;35:e109–11

    Abstract/FREE Full Text
33. ↵
    Versnick EJ, Do HM, Albers GW, et al. Mechanical thrombectomy for acute stroke. AJNR Am J Neuroradiol 2005;26:875–79

    Abstract/FREE Full Text
34. ↵
    Mahon BR, Nesbit GM, Barnwell SL, et al. North American clinical experience with the EKOS MicroLysUS infusion catheter for the treatment of embolic stroke. AJNR Am J Neuroradiol 2003;24:534–38

    Abstract/FREE Full Text
35. Berlis A, Lutsep H, Barnwell S, et al. Mechanical thrombolysis in acute ischemic stroke with endovascular photoacoustic recanalization. Stroke 2004;35:1112–16. Epub 2004 Mar 11

    Abstract/FREE Full Text
36. ↵
    Bellon RJ, Putman CM, Budzik RF, et al. Rheolytic thrombectomy of the occluded internal carotid artery in the setting of acute ischemic stroke. AJNR Am J Neuroradiol 2001;22:526–30

    Abstract/FREE Full Text
37. ↵
    del Zoppo GJ, Higashida RT, Furlan AJ, et al. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke—PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism. Stroke 1998;29:4–11

    Abstract/FREE Full Text
38. ↵
    Kase CS, Furlan AJ, Wechsler LR, et al. Cerebral hemorrhage after intra-arterial thrombolysis for ischemic stroke: the PROACT II trial. Neurology 2001;57:1603–10

    Abstract/FREE Full Text
39. ↵
    Lo EH, Dalkara T, Moskowitz MA. Mechanisms, challenges and opportunities in stroke. Nat Rev Neurosci 2003;4:399–415

    CrossRefPubMedWeb of Science
40. ↵
    Baron JC. Perfusion thresholds in human cerebral ischemia: historical perspective and therapeutic implications. Cerebrovasc Dis 2001;11(suppl 1):2–8
41. Ginsberg MD, Pulsinelli WA. The ischemic penumbra, injury thresholds, and the therapeutic window for acute stroke. Ann Neurol 1994;36:553–54

    CrossRefPubMedWeb of Science
42. Hossmann KA. Viability thresholds and the penumbra of focal ischemia. Ann Neurol 1994;36:557–65

    CrossRefPubMedWeb of Science
43. ↵
    Markus R, Reutens DC, Kazui S, et al. Hypoxic tissue in ischaemic stroke: persistence and clinical consequences of spontaneous survival. Brain 2004;127(Pt 6):1427–36
44. ↵
    Jones TH, Morawetz RB, Crowell RM, et al. Thresholds of focal cerebral ischemia in awake monkeys. J Neurosurg 1981;54:773–82

    PubMedWeb of Science
45. ↵
    Heiss WD, Kracht LW, Thiel A, et al. Penumbral probability thresholds of cortical flumazenil binding and blood flow predicting tissue outcome in patients with cerebral ischaemia. Brain 2001;124(Pt 1):20–29
46. ↵
    Karonen JO, Liu Y, Vanninen RL, et al. Combined perfusion- and diffusion-weighted MR imaging in acute ischemic stroke during the 1st week: a longitudinal study. Radiology 2000;217:886–94

    PubMedWeb of Science
47. Ostergaard L, Weisskoff RM, Chesler DA, et al. High resolution of cerebral blood flow using intravascular tracer bolus passages. Part I. Mathematical approach and statistical analysis. Magn Reson Med 1996;36:715–25

    CrossRefPubMedWeb of Science
48. Rordorf G, Koroshetz WJ, Copen WA, et al. Regional ischemia and ischemic injury in patients with acute middle cerebral artery stroke as defined by early diffusion-weighted and perfusion-weighted MRI. Stroke 1998;29:939–43

    Abstract/FREE Full Text
49. ↵
    Mullins ME, Schaefer PW, Sorensen AG, et al. CT and conventional and diffusion-weighted MR imaging in acute stroke: study in 691 patients at presentation to the emergency department. Radiology 2002;224:353–60

    PubMedWeb of Science
50. Schaefer PW, Ozsunar Y, He J, et al. Assessing tissue viability with MR diffusion and perfusion imaging. AJNR Am J Neuroradiol 2003;24:436–43

    Abstract/FREE Full Text
51. ↵
    Schlaug G, Benfield A, Baird AE, et al. The ischemic penumbra: operationally defined by diffusion and perfusion MRI. Neurology 1999;53:1528–37

    Abstract/FREE Full Text
52. ↵
    Hunter GJ, Hamberg LM, Ponzo JA, et al. Assessment of cerebral perfusion and arterial anatomy in hyperacute stroke with three-dimensional functional CT: early clinical results. AJNR Am J Neuroradiol 1998;19:29–37

    Abstract
53. ↵
    Ay H, Buonanno FS, Rordorf G, et al. Normal diffusion-weighted MRI during stroke-like deficits. Neurology 1999;52:1784–92

    Abstract/FREE Full Text
54. Thijs VN, Adami A, Neumann-Haefelin T, et al. Relationship between severity of MR perfusion deficit and DWI lesion evolution. Neurology 2001;57:1205–11

    Abstract/FREE Full Text
55. ↵
    Grant PE, He J, Halpern EF, et al. Frequency and clinical context of decreased apparent diffusion coefficient reversal in the human brain. Radiology 2001;221:43–50

    PubMedWeb of Science
56. ↵
    Yamada K, Wu O, Gonzalez RG, et al. Magnetic resonance perfusion-weighted imaging of acute cerebral infarction: effect of the calculation methods and underlying vasculopathy. Stroke 2002;33:87–94

    Abstract/FREE Full Text
57. ↵
    Berzin T, Lev M, Goodman D, et al. CT perfusion imaging versus MR diffusion weighted imaging: prediction of final infarct size in hyperacute stroke [abstract]. Stroke 2001;32:317
58. Cenic A, Nabavi DG, Craen RA, et al. Dynamic CT measurement of cerebral blood flow: a validation study. AJNR Am J Neuroradiol 1999;20:63–73

    Abstract/FREE Full Text
59. ↵
    Eastwood D, Lev MH, Azhari T, et al. CT perfusion scanning with deconvolution analysis: pilot study in patients with acute middle cerebral artery stroke. Radiology 2002;222:227–36

    PubMedWeb of Science
60. Ezzeddine MA, Lev MH, McDonald CT, et al. CT angiography with whole brain perfused blood volume imaging: added clinical value in the assessment of acute stroke. Stroke 2002;33:959–66

    Abstract/FREE Full Text
61. Klotz E, Konig M. Perfusion measurements of the brain: using the dynamic CT for the quantitative assessment of cerebral ischemia in acute stroke. Eur J Radiol 1999;30:170–84

    CrossRefPubMed
62. Koenig M, Klotz E, Luka B, et al. Perfusion CT of the brain: diagnostic approach for early detection of ischemic stroke. Radiology 1998;209:85–93

    PubMedWeb of Science
63. Lee KH, Cho SJ, Byun HS, et al. Triphasic perfusion computed tomography in acute middle cerebral artery stroke: a correlation with angiographic findings. Arch Neurol 2000;57:990–99

    CrossRefPubMedWeb of Science
64. Nabavi DG, Cenic A, Henderson S, et al. Perfusion mapping using computed tomography allows accurate prediction of cerebral infarction in experimental brain ischemia. Stroke 2001;32:175–83

    Abstract/FREE Full Text
65. Rother J, Jonetz-Mentzel L, Fiala A, et al. Hemodynamic assessment of acute stroke using dynamic single-slice computed tomographic perfusion imaging. Arch Neurol 2000;57:1161–66

    CrossRefPubMed
66. ↵
    Wildermuth S, Knauth M, Brandt T, et al. Role of CT angiography in patient selection for thrombolytic therapy in acute hemispheric stroke. Stroke 1998;29:935–38

    Abstract/FREE Full Text
67. ↵
    Lovblad KO, Laubach HJ, Baird AE, et al. Clinical experience with diffusion-weighted MR in patients with acute stroke. AJNR Am J Neuroradiol 1998;19:1061–66

    Abstract
68. Marks MP, de Crespigny A, Lentz D, et al. Acute and chronic stroke: navigated spin-echo diffusion-weighted MR imaging. Radiology 1996;199:403–08

    PubMedWeb of Science
69. ↵
    Schaefer PW, Grant PE, Gonzalez RG. Diffusion-weighted MR imaging of the brain. Radiology 2000;217:331–45

    CrossRefPubMedWeb of Science
70. ↵
    Kidwell CS, Saver JL, Starkman S, et al. Late secondary ischemic injury in patients receiving intraarterial thrombolysis. Ann Neurol 2002;52:698–703

    CrossRefPubMedWeb of Science
71. ↵
    Schaefer PW, Hassankhani A, Putman C, et al. Characterization and evolution of diffusion MR imaging abnormalities in stroke patients undergoing intra-arterial thrombolysis. AJNR Am J Neuroradiol 2004;25:951–57

    Abstract/FREE Full Text
72. ↵
    Sorensen AG, Buonanno FS, Gonzalez RG, et al. Hyperacute stroke: evaluation with combined multisection diffusion-weighted and hemodynamically weighted echo-planar MR imaging. Radiology 1996;199:391–401

    PubMedWeb of Science
73. Sunshine JL, Tarr RW, Lanzieri CF, et al. Hyperacute stroke: ultrafast MR imaging to triage patients prior to therapy. Radiology 1999;212:325–32

    PubMedWeb of Science
74. Warach S. Measurement of the ischemic penumbra with MRI: it’s about time. Stroke 2003;34:2533–34

    FREE Full Text
75. Barber PA, Darby DG, Desmond PM, et al. Prediction of stroke outcome with echo planar perfusion- and diffusion-weighted MRI. Neurology 1998;51:418–26

    Abstract/FREE Full Text
76. Rohl L, Ostergaard L, Simonsen CZ, et al. Viability thresholds of ischemic penumbra of hyperacute stroke defined by perfusion-weighted MRI and apparent diffusion coefficient. Stroke 2001;32:1140–46

    Abstract/FREE Full Text
77. Grandin CB, Duprez TP, Smith AM, et al. Usefulness of magnetic resonance-derived quantitative measurements of cerebral blood flow and volume in prediction of infarct growth in hyperacute stroke. Stroke 2001;32:1147–53

    Abstract/FREE Full Text
78. Wittsack HJ, Ritzl A, Fink GR, et al. MR imaging in acute stroke: diffusion-weighted and perfusion imaging parameters for predicting infarct size. Radiology 2002;222:397–403

    PubMedWeb of Science
79. ↵
    Grandin CB. Assessment of brain perfusion with MRI: methodology and application to acute stroke. Neuroradiology 2003;45:755–66

    CrossRefPubMed
80. ↵
    Hacke W, Albers G, Al-Rawi Y, et al. The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 2005;36:66–73. Epub 2004 Nov 29

    Abstract/FREE Full Text
81. ↵
    Ribo M, Molina CA, Rovira A, et al. Safety and efficacy of intravenous tissue plasminogen activator stroke treatment in the 3- to 6-hour window using multimodal transcranial Doppler/MRI selection protocol. Stroke 2005;36:602–06

    Abstract/FREE Full Text
82. ↵
    Schramm P, Schellinger PD, Klotz E, et al. Comparison of perfusion computed tomography and computed tomography angiography source images with perfusion-weighted imaging and diffusion-weighted imaging in patients with acute stroke of less than 6 hours’ duration. Stroke 2004;35:1652–58. Epub 2004 May 20

    Abstract/FREE Full Text
83. ↵
    Aksoy FG, Lev MH. Dynamic contrast-enhanced brain perfusion imaging: technique and clinical applications. Semin Ultrasound CT MR 2000;21:462–77

    CrossRefPubMedWeb of Science
84. ↵
    Kidwell CS, Chalela JA, Saver JL, et al. Comparison of MRI and CT for detection of acute intracerebral hemorrhage. JAMA 2004;292:1823–30

    CrossRefPubMedWeb of Science
85. ↵
    Lev MH, Farkas J, Rodriguez VR, et al. CT angiography in the rapid triage of patients with hyperacute stroke to intraarterial thrombolysis: accuracy in the detection of large vessel thrombus. J Comput Assist Tomogr 2001;25:520–28

    CrossRefPubMed
86. ↵
    Shetty SK, Lev MH. CT perfusion in acute stroke. Neuroimaging Clin N Am 2005;15:481–501, ix

    CrossRefPubMed